TP53 and cancer: Shortly after, the Asian Cancer Research Group (ACRG) presented a further classification, again with four subgroups, namely MSI-high, microsatellite stable/epithelial mesenchymal transition (MSS/EMT), MSS/p53 intact and MSS/p53 loss [15].